European Patent Office Declares Medinol Patent Invalid

Law360, New York (April 2, 2004, 12:00 AM EST) -- The European Patent Office has invalidated a patent for drug-coated stents, which has been at the center of a dispute between medical device makers Medinol and Boston Scientific in the Netherlands.

As a result, the injunction against the sale of these products in The Netherlands is no longer effective, Boston Scientific said.

The medical device maker said it expects to recommence sales in the Netherlands immediately.

The European Patent Office's decision is final and not appealable.

Boston Scientific said it is considering whether to seek damages...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.